Process View
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat3 protein.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of tyrosine phosphorylation of stat3 protein"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 1.000 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.999 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.999 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.998 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.998 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.994 | Human | |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.979 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.966 | ||
| CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.961 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.947 | ||
| LAT | linker for activation of T cells | 0.943 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.924 | Human | |
| IL6R | interleukin 6 receptor | 0.899 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.898 | ||
| JAK1 | Janus kinase 1 | 0.872 | ||
| GH1 | growth hormone 1 | 0.870 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.841 | ||
| HDAC2 | histone deacetylase 2 | 0.839 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.831 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.830 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.800 | ||
| JAK2 | Janus kinase 2 | 0.733 | Mouse | |
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.718 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.696 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.610 | ||
| CSH2 | chorionic somatomammotropin hormone 2 | 0.595 | Human | |
| NRP1 | neuropilin 1 | 0.593 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.545 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.465 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.422 | Human | |
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.406 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.402 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.397 | Human | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.382 | Human | |
| SOCS1 | suppressor of cytokine signaling 1 | 0.382 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.358 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.348 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.326 | ||
| INSR | insulin receptor | 0.326 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.311 | ||
| CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.305 | Human | |
| GHR | growth hormone receptor | 0.272 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.233 | ||
| GH2 | growth hormone 2 | 0.227 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.208 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.202 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.162 | ||
| IRS1 | insulin receptor substrate 1 | 0.159 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.137 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.131 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.125 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.124 | ||
| PGF | placental growth factor | 0.124 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.119 | ||
| FGF10 | fibroblast growth factor 10 | 0.113 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.102 | Human | |
| FGF7 | fibroblast growth factor 7 | 0.095 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.094 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.094 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.087 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.079 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.076 | ||
| CD33 | CD33 molecule | 0.068 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.068 | ||
| CNTF | ciliary neurotrophic factor | 0.063 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.062 | Human | |
| PDGFC | platelet derived growth factor C | 0.060 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.056 | ||
| SYK | spleen tyrosine kinase | 0.052 | ||
| JAK3 | Janus kinase 3 | 0.051 | ||
| KITLG | KIT ligand | 0.050 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.049 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.047 | ||
| SLA | Src-like-adaptor | 0.045 | ||
| KRT8 | keratin 8 | 0.043 | ||
| CMIP | c-Maf-inducing protein | 0.039 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.038 | ||
| CD28 | CD28 molecule | 0.037 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.036 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.035 | ||
| EPOR | erythropoietin receptor | 0.031 | ||
| OSMR | oncostatin M receptor | 0.031 | Human | |
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.030 | ||
| EXT1 | exostosin 1 | 0.030 | ||
| LDLR | low density lipoprotein receptor | 0.030 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.030 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.028 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.028 | ||
| CDK9 | cyclin-dependent kinase 9 | 0.027 | ||
| IL8 | interleukin 8 | 0.027 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.027 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.027 | ||
| STC1 | stanniocalcin 1 | 0.026 | ||
| OSM | oncostatin M | 0.026 | ||
| AXL | AXL receptor tyrosine kinase | 0.025 | ||
| CSNK1E | casein kinase 1, epsilon | 0.024 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.024 | ||
| DHX30 | DEAH (Asp-Glu-Ala-His) box polypeptide 30 | 0.024 | ||
| IL10 | interleukin 10 | 0.024 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.023 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.023 | ||
| ICA1 | islet cell autoantigen 1, 69kDa | 0.023 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.023 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.020 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.020 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.020 | ||
| PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.019 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.018 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.018 | ||
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.017 | Human | |
| HDAC3 | histone deacetylase 3 | 0.017 | ||
| MAP1S | microtubule-associated protein 1S | 0.017 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.017 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.017 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.016 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.016 | ||
| IFNA16 | interferon, alpha 16 | 0.016 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.016 | ||
| IL1B | interleukin 1, beta | 0.015 | ||
| VEGFC | vascular endothelial growth factor C | 0.014 | ||
| MPZL1 | myelin protein zero-like 1 | 0.014 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.013 | ||
| FOSL1 | FOS-like antigen 1 | 0.013 | ||
| GYPB | glycophorin B (MNS blood group) | 0.013 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.013 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.012 | ||
| KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 0.012 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.012 | ||
| TLR3 | toll-like receptor 3 | 0.012 | ||
| RBBP7 | retinoblastoma binding protein 7 | 0.012 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.011 | ||
| IFNA10 | interferon, alpha 10 | 0.011 | Human | |
| IFNA4 | interferon, alpha 4 | 0.011 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.011 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.011 | ||
| AKAP2 | A kinase (PRKA) anchor protein 2 | 0.011 | ||
| HRH1 | histamine receptor H1 | 0.010 |